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From the Rarest to the Most Common: Insights from
Progeroid Syndromes into Skin Cancer and Aging
Brian C. Capell1, Brook E. Tlougan1 and Seth J. Orlow1,2
Despite their rarity, diseases of premature aging, or ‘‘progeroid’’ syndromes, have provided important insights
into basic mechanisms that may underlie cancer and normal aging. In this review, we highlight these recent
developments in Hutchinson—Gilford progeria syndrome (HGPS), Werner syndrome, Bloom syndrome,
Cockayne syndrome, trichothiodystrophy, ataxia-telangiectasia, Rothmund–Thomson syndrome, and xeroderma
pigmentosum. Though they are caused by different mutations in various genes and often result in quite
disparate phenotypes, deciphering the molecular bases of these conditions has served to highlight their
underlying basic similarities. Studies of progeroid syndromes, particularly HGPS, the most dramatic form of
premature aging, have contributed to our knowledge of fundamental processes of importance to skin biology,
including DNA transcription, replication, and repair, genome instability, cellular senescence, and stem-cell
differentiation.
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INTRODUCTION
‘‘We ought not to set them aside
with idle thoughts or idle words
about ‘curiosities’ or ‘chances.’ Not
one of them is without meaning; not
one that might not become the
beginning of excellent knowledge,
if only we could answer the ques-
tion - why is it rare or being rare,
why did it in this instance happen?’’
James Paget (1882)
That much may be gleaned from the
study of rare diseases is not a novel
concept, as Sir James Paget so aptly
pronounced in 1882. With the recent
explosion in knowledge arising from
the study of rare syndromes associated
with premature aging, especially the
most dramatic form of human prema-
ture aging, Hutchinson–Gilford proger-
ia syndrome (HGPS), this statement
has taken on a new relevance. In
1886, a mere 4 years following Paget’s
statement, Jonathan Hutchinson first
described progeria, though it would
be another 117 years before the genetic
mutation that causes HGPS was identi-
fied. This discovery opened the flood-
gates for progeria research, and within
just 4 years, the first-ever clinical trial
for HGPS had begun, an unprece-
dented timeframe for such a rare
disease.
Similar advances in our understand-
ing of other progeroid syndromes,
including Werner syndrome (WS),
Bloom syndrome (BS), Cockayne syn-
drome (CS), trichothiodystrophy (TTD),
ataxia-telangiectasia (AT), Rothmund
–Thomson syndrome (RTS), and xero-
derma pigmentosum (XP) (Table S1),
have been made recently. The knowl-
edge gained from the study of these
conditions has provided insights into
fundamental basic processes such as
DNA transcription, replication, and
repair, genome instability, nuclear
architecture, chromatin organization,
cellular senescence, and stem-cell
differentiation. These processes,
although distinct, are all intercon-
nected and of critical importance not
only for normal skin homeostasis, but
also as regulators of skin changes
with age and cancerous transformation.
Given its easy accessibility, the skin
is an ideal model organ in which to
study aging and cancer, and many of
the fundamental findings in each
have been made by studying skin
biopsies and fibroblast cultures.
Although much has been described
regarding the effects of age on the skin
and benign and malignant skin
growths, many questions remain as to
the exact causes and mechanisms
behind these changes, as well as
how these changes can be controlled,
prevented, or even reversed. With
Paget’s vision in mind, in this review
we have attempted to highlight the
latest findings relating to these rare
conditions, with a particular focus on
HGPS, and how these recent advances
might have relevance to answering
these questions.
PERSPECTIVE
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PROVIDING STRUCTURE AND
ORGANIZATION: NUCLEAR
ARCHITECTURE AND GENOME
INTEGRITY
As the command center of the cell, it is
not surprising that the nucleus is the
focus of global alterations that occur in
normal skin aging and cancer. As
discussed here, several of the nuclear
abnormalities encountered in HGPS
are relevant to all individuals. On the
phenotypic level, children with HGPS
look normal at birth. The first signs of
the disease are typically skin changes,
including either hyper- or hypopigmen-
ted patches or nonspecific scleroder-
matous changes that appear from 6 to
18 months of age (Figure 1). HGPS
patients then display progressively nu-
merous other manifestations reminis-
cent of normal aging such as alopecia,
skin wrinkling, osteopenia, and athero-
sclerosis (Figure 1 and Table S1)
(Merideth et al., 2008). Death fre-
quently occurs in early adolescence
due to heart attacks or strokes (Capell
et al., 2007). On a cellular level, HGPS
nuclei take on a progressively blebbed
and lobulated appearance with age
(Goldman et al., 2004). These altera-
tions portend the changes taking place
inside the nucleus, represented by
mislocalized nuclear envelope pro-
teins, disrupted heterochromatin orga-
nization, and greatly misregulated gene
expression (Capell and Collins, 2006).
The disease, dramatic in phenotype
on both the organismal and cellular
levels, was discovered to be due to a
single base change (1824C4T) in the
LMNA gene that does not even change
the encoded amino acid (G608G) (De
Sandre-Giovannoli et al., 2003;
Eriksson et al., 2003). Through activa-
tion of a cryptic splice site, this muta-
tion produces a mutant version of
the lamin A protein, a component of
the dynamic scaffolding network of the
nucleus, the nuclear lamina, which lies
just inside the inner nuclear mem-
brane. This mutant lamin A precursor
(prelamin A), termed ‘‘progerin’’, con-
tains a 50 amino acid internal deletion
that results in its permanent modifica-
tion by a 15-carbon lipid farnesyl group
added post-translationally by the en-
zyme farnesyltransferase (Eriksson
et al., 2003; Dechat et al., 2007). It is
believed that this lipid chain serves as a
toxic anchor, binding progerin to the
nuclear envelope and preventing its
insertion into the lamina; thus acting in
a dominant-negative manner to lead to
all of the downstream nuclear defects
(Figure 2) (Scaffidi and Misteli, 2005),
and ultimately the HGPS clinical phe-
notype. Several studies in both HGPS
skin fibroblasts (Capell et al., 2005;
Glynn and Glover, 2005; Mallampalli
et al., 2005; Toth et al., 2005) and
mouse models (Fong et al., 2006; Yang
et al., 2006; Capell et al., 2008) have
shown that inhibiting this farnesylation
step pharmacologically by use of a
class of anti-cancer drugs known as
farnesyltransferase inhibitors can pre-
vent disease phenotypes. Furthermore,
that the HGPS phenotype might even
be reversible has been suggested by
two studies, one where an farnesyl-
transferase inhibitor reversed the cardi-
ovascular phenotype of a transgenic
mouse model (Capell et al., 2008), and
another where suppressing the expres-
sion of progerin using an inducible
transgenic system led to the reversal of
a severe skin phenotype that involved
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Figure 1. Clinical features of progeroid syndromes. (a–j) Hutchinson—Gilford progeria syndrome (Merideth et al., 2008) (Copyright 2008 Massachusetts
Medical Society. All rights reserved.). (a) Shows short stature at 21 months of age. (b) Shows alopecia at 4 years of age and an even further progression of
premature aging in Panel c at age 7. (d) Shows prominent veins, knee joints, and contractures under maximal passive extension. (e) Shows tufting of fingers.
(f) Shows phalangeal joint contractures. (g) Shows dimpling in the left leg. (h) Shows areas of hypopigmented skin. (i) Shows abdominal outpouching and
reticulated hyperpigmented skin interspersed with hypopigmented skin. (j) Shows circumoral cyanosis. (k, l) Werner syndrome (Adoue, 1997) (Copyright 1997
Massachusetts Medical Society. All rights reserved.). (k) Shows a 37-year-old man the characteristic beak-like appearance of Werner’s syndrome. Further
examination of this patient demonstrated scleroderma-like skin changes and sensory neuropathy of the lower limbs (Panel l). (m) Shows the face of a teenager
with XP due to a mutated XPC. Mottled pigmentation and scars from multiple surgeries to remove skin cancers are evident. (n) Shows a longstanding leg ulcer on
the ankle of an 8-year-old boy with Rothmund—Thomson syndrome. Patients gave written consent for the publication of clinical photographs.
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fibrosis, loss of subdermal adipocytes,
and structural defects in the hair
follicles and sebaceous glands (Sagelius
et al., 2008). These results have served
as the impetus for an ongoing clinical
trial of the efficacy of the farnesyltrans-
ferase inhibitor lonafarnib for HGPS
(Kieran et al., 2007).
Is this potentially important beyond
HGPS? Despite carrying a normal
LMNA sequence, it has now been
shown that all individuals make small
amounts of the mutant progerin protein
due to leaky activation of the afore-
mentioned cryptic splice site (Figure 2)
(Scaffidi and Misteli, 2006; Cao et al.,
2007; Rodriguez et al., 2009). Strik-
ingly, progerin builds up in human skin
with age, localizing mainly in fibro-
blasts of the papillary dermis in young
adults and then proceeding to spread to
the deep reticular dermis and to a few
terminally differentiated keratinocytes
in the elderly (McClintock et al., 2007).
Progerin has no predilection for sun-
exposed areas, even appearing in new-
born foreskin. Furthermore, beyond just
the presence of progerin, skin samples
from aged individuals also display
nuclear defects similar to those of
HGPS patients. The presence of pro-
gerin in aged skin led to similar
changes in nuclear morphology, his-
tone modifications, upregulation of p53
target genes, as well as increased levels
of unrepaired DNA damage (Figure 2).
Remarkably, silencing the production
of progerin by using an antisense
oligonucleotide reversed all of these
nuclear defects associated with aging,
thus implicating this mutant lamin A in
physiological and skin aging (Scaffidi
and Misteli, 2006).
These data are all the more compel-
ling considering the growing body of
evidence in both model organisms and
humans suggesting the conserved role
of nuclear architecture, particularly
nuclear lamins (Shimi et al., 2008), in
organizing and regulating chromatin
and the effects that this organization
has on gene expression and cellular
senescence (Oberdoerffer and Sinclair,
2007; Shimi et al., 2008), as well as in
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Figure 2. Progeria and normal aging: common nuclear and phenotypic skin findings. Though normal cells do not possess the typical HGPS LMNA 1824C4T
mutation, leaky activation of a cryptic splice donor site results in the production of small amounts of the mutant prelamin A isoform (represented in blue)
that is missing a final processing cleavage site and is thus permanently modified by a 15-carbon lipid farnesyl group, producing increasing levels of progerin (red)
with age. This mutant version of prelamin A, which is made in abundance in HGPS, leads to the nuclear abnormalities that are characteristic of HGPS
(left side) and that are also seen in nuclei from aged individuals (right side). It should be noted that due to space constraints, the relative amounts of mutant
prelamin A, or progerin, is not precisely represented by this schematic representation. Current data suggests that expression levels in HGPS are greater than
160-fold higher than those seen in unaffected individuals (Rodriguez et al., 2009). These nuclear defects include alterations in normal gene expression, nuclear
blebbing, disorganization of the underlying heterochromatin, stem cell dysfunction, and increased DNA damage, cellular senescence, and p16INK4A levels.
At the organismal level, these nuclear alterations may play a role in the skin findings that are common to both HGPS and normal aging such as wrinkling,
alopecia, loss of hypodermal fat, and alterations in the levels and function of collagen and elastin.
2342 Journal of Investigative Dermatology (2009), Volume 129
BC Capell et al.
From the Rarest to the Most Common
DNA repair (Dimitrova et al., 2008)
and skin cancers like melanoma
(Richards and Medrano, 2009). For
instance, the same changes in nuclear
shape and loss of peripheral hetero-
chromatin organization that are seen in
HGPS are also observed in the normal
aging of Caenorhabditis elegans
(Haithcock et al., 2005). Furthermore,
other diseases due to mutations in
LMNA and presenting with premature
aging phenotypes, mandibuloacral
dysplasia, and restrictive dermopathy
(Table S1), also display dysmorphic
nuclear shape and chromatin altera-
tions due to an accumulation of the
lamin A precursor, prelamin A (Novelli
et al., 2002; Agarwal et al., 2003;
Navarro et al., 2004, 2005; Filesi
et al., 2005; Moulson et al., 2005).
Similarly, WS, due to mutations in
WRN (encoding WRN) and ataxia-
telangiectasia (AT), caused by muta-
tions in the AT-mutated (ATM) gene,
both of which display features of
premature aging, are also characterized
by defective nuclear architecture, chro-
matin changes, and genomic instability
(Adelfalk et al., 2005; Grattarola et al.,
2006) (Table S1). Underscoring the
importance of these relationships, there
have been numerous cases of an
atypical (and more severe form) of
Werner syndrome associated with mu-
tations in LMNA as well (Chen et al.,
2003). As discussed further below, both
ATM and WRN appear to play a role in
telomere maintenance and the relation-
ship of telomeres with the nuclear
matrix (Smilenov et al., 1997; Machwe
et al., 2004), and given the association
between telomere attrition and cellular
senescence (Allsopp et al., 1992) and
aging (Tomas-Loba et al., 2008), the
implications for the roles of these
various genes and their resulting pro-
teins with regard to aging and cancer is
clear.
DNA DAMAGE AND REPAIR GONE
AWRY
It is estimated that each cell undergoes
thousands of strand breaks and various
DNA lesions each day (Lindahl, 1993;
Garinis et al., 2008). Even though
sophisticated mechanisms of genome
maintenance and repair have evolved,
aging is associated with significant
increases in DNA mutations (Vijg,
2000), chromosome losses (Rehen
et al., 2005), and DNA oxidation
(Hamilton et al., 2001) over time. In
addition to intrinsic age-related skin
changes, Ultraviolet-A generates reac-
tive oxygen species that affect lipid
peroxidation and generate DNA dou-
ble-strand breaks. Likewise, within
minutes of exposure, ultraviolet-B
causes thymidine dimer formation that
leads to further DNA damage and
mutations. This oxidative stress may
have many consequences for dermato-
logical conditions (Bickers and Athar,
2006), and repair of this damage is
essential to avoid aging and cancerous
transformation. The progeroid syn-
dromes, though displaying a variety of
phenotypic manifestations and differing
propensities towards precocious aging
or malignant disease, all exhibit some
evidence of increased DNA damage or
defective repair, changes clearly seen
in the human skin with age (Moriwaki
et al., 1996). The study of each condi-
tion has highlighted various aspects of
the DNA damage and repair process.
The first evidence of DNA damage
in HGPS occurred when it was
shown that HGPS dermal fibroblasts
showed an age-dependent reduced
growth and lifespan in culture as well
as a delayed and hypersensitive
response to heat stress (Liu et al.,
2005; Paradisi et al., 2005). It was
later demonstrated that HGPS fibro-
blasts, as well as fibroblasts from
mice lacking the lamin A processing
enzyme, Zmpste24, and thus only
producing unprocessed and perma-
nently farnesylated lamin A, show
increased DNA damage and chromo-
somal aberrations and the mice are
more sensitive to DNA-damaging
agents. Further, the recruitment of
53BP1 and Rad51, both involved in
DNA double-strand break repair, to
sites of DNA damage was defective in
both the HGPS patient and mouse
model fibroblasts, resulting in a de-
layed checkpoint response and im-
paired DNA repair (Liu et al., 2005).
As both mandibuloacral dysplasia and
restrictive dermopathy also show an
accumulation of prelamin A and can
arise due to mutations in ZMPSTE24,
future research should consider the role
DNA damage might play in their
phenotypic manifestations.
Relative to HGPS, in WS, AT,
xeroderma pigmentosum (XP), Bloom
syndrome (BS), TTD, RTS, and
Cockayne syndrome (CS), the genotype–
phenotype correlations between defec-
tive DNA repair and premature aging
and cancer susceptibility are more
clearly established. WS is character-
ized by numerous age-related symp-
toms such as atherosclerosis,
osteoporosis, type II diabetes mellitus,
and an increased susceptibility to
cancer, especially those of mesenchy-
mal origin (Figure 1 and Table S1)
(Muftuoglu et al., 2008). WS patients
have an increased incidence of mela-
noma, particularly acral lentiginous
melanoma of mucosal surfaces, as well
as of skin ulcers on the ankles and
elbows (Goto et al., 1996). As one of
five RecQ helicase proteins, WRN
(RECQL3) is a 180-kDa tumor suppres-
sor with ATPase, helicase, exonu-
clease, and single-stranded DNA
annealing activities (Oshima et al.,
1996; Yu et al., 1996). It is involved
in DNA repair, replication initiation,
establishment of replication foci, reso-
lution of stalled replication forks, and
recombination (Kusumoto et al., 2007).
Most WRN mutations result in the
production of a truncated version of
WRN that lacks its nuclear localization
signal and thus cannot find its way to
the nucleus to perform its usual func-
tions (Matsumoto et al., 1997). WS
cells have telomere shortening, chro-
mosomal rearrangements, increased
susceptibility to malignant transforma-
tion, and frequent telomere fusions. In
all individuals, WRN is involved in the
processing of telomeric DNA and sub-
sequent activation of DNA damage
responses (Eller et al., 2006), thus it is
not surprising that WRN is epigeneti-
cally inactivated in numerous human
cancers and it is required for proper
telomere maintenance (Agrelo et al.,
2006).
Two of the other RecQ helicases are
the mutated proteins of RTS (encoded
by RECQL4) and BS (BLM, encoded by
RECQL2 or BLM). BS is characterized
by a dramatically increased suscept-
ibility to all types of cancers, UV hyper-
sensitivity, hyper- and hypopigmented
www.jidonline.org 2343
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skin changes, decreased subcutaneous
fat, immune deficiency, anemia, in-
creased susceptibility to type II diabetes
mellitus, severe growth retardation,
and death by the age of 30 usually
due to cancer (Table S1) (Ellis et al.,
1995; Hanada and Hickson, 2007;
Ouyang et al., 2008). BLM colocalizes
and appears to work in concert with
WRN during DNA repair. BLM is
necessary for normal double-stranded
break repair (Langland et al., 2002). It
was very recently discovered that BLM
is stabilized by the protein RMI2, and
that the two proteins form a complex to
suppress sister-chromatid exchange
(Singh et al., 2008; Xu et al., 2008). In
the absence of this properly functioning
complex, homologous recombination
events occur at a ten-fold increased
level. This hyper-recombination and
defective DNA repair leads to a 150-
to 300-fold increased risk of cancer.
Underscoring the conserved and cen-
tral role of these proteins in genome
stability and aging, yeast lacking
the WRN and BLM homolog, SGS1,
also undergo premature age-related
changes, including cell-cycle arrest
defects, more frequent chromosomal
rearrangements, and an age-related
increase in DNA mutations (Madia
et al., 2008).
Clinically, RTS is characterized by
poikiloderma, sparse hair, small sta-
ture, skeletal abnormalities, cataracts,
and an increased risk of cancer (Fig-
ure 1 and Table S1) (Jin et al., 2008).
Compared with WRN and BLM, less is
known about RecQ4, the protein mu-
tated in RTS, though it shares structural
similarity to WRN and BLM, as well as
very recently demonstrated helicase
activity (Xu and Liu, 2009). The end
result is also similar as RTS cells exhibit
marked genomic instability and chro-
mosomal rearrangements. Studies in
both RTS fibroblasts as well as in model
organisms have demonstrated that
RecQ4 is necessary for initiating DNA
replication and proliferation (Sangrithi
et al., 2005; Wu et al., 2008), and is
also involved in the repair of DNA
damage induced by UV irradiation (Fan
and Luo, 2008). It is speculated that
the increased sensitivity to oxidant
damage seen in RTS induces premature
senescence and is also responsible for
the increased susceptibility to osteosar-
comas and cutaneous epithelial neo-
plasms such as squamous and basal
cell carcinomas (Stinco et al., 2008).
CS, characterized by neurological
abnormalities as well as atrophic skin,
loss of subcutaneous fat, sparse hair,
and increased sun sensitivity, is due to
mutations in CSA or CSB, which
encode CSA and CSB, components of
the transcription-coupled nucleotide
excision repair system (TC-NER) (Table
S1) (Stevnsner et al., 2008). Approxi-
mately 80% of CS cases are due to
mutations in CSB (Mallery et al., 1998).
TC-NER, which along with global
genome nucleotide excision repair
(GG-NER), make up the two subpath-
ways of nucleotide excision repair,
recognizes damage marked by stalled
RNA polymerase II complexes. TC-NER
then removes the damaged or erro-
neous oligonucleotide and allows RNA
synthesis to resume (Puzianowska-Kuz-
nicka and Kuznicki, 2005). During the
unwinding step of TC-NER, CSA, and
CSB work in concert with TFIIH, a
transcription factor protein complex
consisting of 10 subunits required for
both NER and transcription. Upon
exposure to UV irradiation, TFIIH and
CSB allow TC-NER to occur by bring-
ing about the necessary alterations in
chromatin structure at the RNA poly-
merase II stall site and the transport of
CSA to the nuclear matrix (Saijo et al.,
2007). Beyond these critical functions,
CSB also plays a key role in mediating
the hypoxic response pathway (Filippi
et al., 2008) as well as in chromatin
structure (Stevnsner et al., 2008).
Further highlighting the overlapping
basic mechanisms and phenotypes of
these conditions, mutations in some
components of TFIIH can lead to TTD
(Stefanini et al., 1993; Vermeulen et al.,
2000; Giglia-Mari et al., 2004). TTD is
characterized by sulfur and cystine-
deficient brittle hair, developmental
delay or intellectual impairment, short
stature, ichthyosis, ocular abnormal-
ities, photosensitivity, infections, and
defective DNA repair of oxidative
lesions (Table S1) (Liang et al., 2006;
Faghri et al., 2008). Most cases of TTD
are due to mutations in the XPD
component of TFIIH. The structure of
XPD was recently determined and has
demonstrated that XPD’s main function
is in catalyzing DNA duplex opening at
either transcriptional start sites or sites
of DNA damage (Fan et al., 2008; Liu
et al., 2008a). In TTD cells, mutated
subunits of TFIIH prevent it from
accessing UV-induced DNA damage
in regions of closed chromatin
(Chigancas et al., 2008). A mouse
model of TTD that display many of
the phenotypic characteristics of TTD,
such as brittle hair, UV sensitivity, and
premature aging, suggests that the
disease is caused by unrepaired DNA
damage that ultimately compromises
transcription, leading to functional
inactivation of critical genes and en-
hanced apoptosis (de Boer et al., 2002).
For example, reduced levels of tran-
scription of cystine and sulfur-rich
matrix proteins, which are expressed
late in terminal differentiation of the
hair follicle may be responsible for the
brittle nature of hair seen in both TTD
patients and mice (Price et al., 1980; de
Boer et al., 1998; Liang et al., 2006).
XP often presents with an unusual
susceptibility to prolonged sunburn and
is characterized by a more than 1000-
fold increased susceptibility to sun-
induced skin cancers due to deficient
GG-NER (Table S1) (Kraemer et al.,
1987; Garinis et al., 2008). Clinically,
all XP patients exhibit increased
freckle-like pigmentation with minimal
sun exposure, usually first appearing in
children before 2 years of age (Figure 1).
Just as strikingly, skin cancer has an
onset at a mean age of less than 10 in
XP (Kraemer et al., 2007). XP is
autosomal recessive and associated
with seven genes (XPA through XPG)
(Sugasawa, 2008), as well as a variant
form (‘‘XP-V’’) due to mutations in the
DNA polymerase eta, leading to defec-
tive translesion synthesis (Masutani
et al., 1999). In addition to CSA and
CSB, all the XP gene products
(types A–G) are likewise involved in
TC-NER, and in addition to the distinct
phenotypic entities of XP, CS, and
TTD, there are combined syndromes
such as XP-CS and XP-TTD caused by
mutations in certain XP genes (for
example, XPB, XPD, and XPG). Char-
acterizing the various phenotypic
presentations of these overlapping con-
ditions has assisted in dissecting out the
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mechanisms of disease. For instance,
although CS involves neurodegenera-
tion but not an increased risk of skin
cancer, the reverse is true in XPA,
suggesting that although neoplastic
transformation entails global genome
instability comprised of copy number
changes and aneuploidy, neurodegen-
eration results from precise transcrip-
tional alterations and protein modi-
fications (Cleaver, 2005). Defects in
TC-NER may thus be anti-cancer, but
pro-aging, leading to cell death or
senescence when transcription is un-
able to go on (Garinis et al., 2008).
Interestingly, it has been noted that in
HGPS, XPA localizes with double-
strand breaks caused by accumulation
of the permanently farnesylated
progerin (Liu et al., 2008b).
Elucidating the precise pathways
through which DNA damage leads to
organismal aging has been challenging.
Niedernhofer et al. (2006) described a
patient with a severe mutation in XPF,
which encodes XPF-ERCC1, an endo-
nuclease required for the repair of
helix-distorting DNA lesions and cyto-
toxic DNA interstrand cross-links. Mild
mutations in XPF cause XP. However,
in this case, the patient had severe
progeroid symptoms. Upon creating a
mouse model of this syndrome, they
demonstrated that the mice displayed a
survival response marked by increased
cell death and anti-oxidant defenses, a
shift towards anabolism and suppres-
sion of growth hormone/insulin-like
growth factor 1 (GH/IGF1) signaling.
Similar changes were seen in wild-type
mice in response to chronic genotoxic
stress, calorie restriction, and aging. As
this response is also seen in a mouse
model of CS, as well as in wild-type
mice exposed to low doses of geno-
toxic stress (van der Pluijm et al.,
2007), the authors concluded that
unrepaired cytotoxic DNA damage
induces a highly conserved metabolic
response mediated by the IGF1/insulin
pathway, which reallocates resources
from growth to somatic preservation
and lifespan extension, uncovering a
direct link between DNA damage and
aging (Niedernhofer et al., 2006).
Similarly, reduced expression of IGF1
has also been reported in skin from
aged individuals, and some work
suggests that this reduced signaling
might contribute to the increased pre-
valence of ultraviolet-B-induced skin
cancer seen in aged individuals (Lewis
et al., 2009).
AT is characterized by early onset
cerebellar ataxia, oculocutaneous tel-
angiectasias, and increased vulnerabil-
ity to pulmonary disease, and lymphoid
tumors (Table S1) (Boder, 1985). It is
caused by mutations in the AT-mutated
gene (ATM), encoding ATM, a serine/
threonine protein kinase, which along
with ‘‘ATM and Rad3-related protein’’
(ATR), serves to recognize and respond
to DNA double-strand breaks to main-
tain genome stability and thus inhibit
neoplastic transformation and neurode-
generation. AT cells display cell-cycle
checkpoint defects such as a failure to
activate the G1-S checkpoint through
the inability to stabilize p53, one of
ATM’s many substrates (Lavin, 2008),
and the often-termed ‘‘guardian of
the genome’’ (Lane, 1992) (discussed
further in the next section). Again,
underscoring the many overlapping
basic mechanisms of disease, expres-
sing numerous progeroid mutations
(including the common HGPS muta-
tion, LMNA G608G) in different cell
lines compromises the ability of DNA
repair foci to form in response to
cisplatin or UV radiation and results
in mislocalization of ATR, a key sensor
in the response to DNA damage (Manju
et al., 2006).
OLD AND BEYOND REPAIR: TUMOR
SUPPRESSORS AND CELLULAR
SENESCENCE
With all of the possible damage to cells
that can accrue with age, it is not
surprising that mechanisms have
evolved for removal of this damage.
Similarly, these processes doubly serve
as protection against uncontrolled cel-
lular growth or cancer. Among these
mechanisms, the one most closely
implicated with cancer and aging is
irreversible cell-cycle arrest, or cellular
senescence.
Age-related increases in the number
of senescent dermal fibroblasts and
epidermal keratinocytes have been
observed (Dimri et al., 1995), as well
as increases in markers of the senes-
cence phenotype in the skin (Francis
et al., 2004). Similarly, recent work
suggests that fibroblast dysfunction
secondary to oxidative stress and
marked by premature senescence may
be responsible for age-related pheno-
types such as decreased wound healing
capabilities (Wall et al., 2008). Con-
sidering that progerin is more abundant
in late-passage cells and in the dermis
of aged individuals, it is suggestive of a
possible role for progerin in age-related
increases in cellular senescence
(McClintock et al., 2007). Likewise, in
addition to senescence, recent data
from the study of a mouse model of
progeria show that the permanently
farnesylated lamin A precursor leads
to a chronically overactive induction of
autophagy, and opens up a new area of
exploration of the role of this catabolic
pathway in aging (Marino et al., 2008;
Vellai, 2009).
Concerning senescence, mouse
models of HGPS and other laminopa-
thies, as well as HGPS cells, are
notable for undergoing a period hyper-
proliferation prior to senescing prema-
turely (Bridger and Kill, 2004). Others
have shown that exogenous expression
of progerin leads to reduced cellular
proliferation and premature senescence
(Kudlow et al., 2008). These effects
were reversible upon either suppressing
p53 expression or inducing the expres-
sion of the catalytic subunit of telomer-
ase. These results were significant as
they supported previous findings in a
mouse model of HGPS of a correspon-
dence between an upregulation of p53
target genes and the senescent pheno-
type at both the cellular and organismal
level (Varela et al., 2005). Likewise,
they suggested a possible role of
progerin in causing defective telomere
structure or metabolism (Grove and
Kligman, 1983; Kudlow et al., 2008).
Both activated p53 (Choudhury et al.,
2007) and oxidative DNA damage
(d’Adda di Fagagna et al., 2003) have
been shown to accelerate telomere
shortening and promote senescence. It
should be noted, however, that the role
of progerin in causing defective telo-
mere function has never been proven
directly in a physiological setting.
Recent work demonstrates that over-
expression of even wild-type lamin A
can lead to accelerated telomere loss
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and shortened replicative lifespan
(Huang et al., 2008), supporting the
previously suggested hypothesis that
progerin might exert some of its dele-
terious effects simply by altering the
normal ratio and segregation of the
nuclear lamins A and B (Delbarre et al.,
2006). Notably, altered lamin expres-
sion levels have been observed in both
premalignant as well as malignant
lesions of the skin (Oguchi et al.,
2002; Tilli et al., 2003), as well as in
other common neoplasms (Willis et al.,
2008).
As discussed further in the next
section, in addition to p53, another
tumor suppressor, p16INK4A, helps to tie
together the concepts of age-related
genome instability, cancerous transfor-
mation, senescence, and stem-cell dys-
function. It has been shown that both
senescing human skin fibroblasts and
aging mice accumulate DNA lesions
with irreparable double-strand breaks
(Sedelnikova et al., 2004). More speci-
fically, dermal fibroblasts from both
aged human and baboon skin display
DNA damage foci as represented by g-
H2AX, activated ATM kinase, and
53BP1 (a marker of DNA double-strand
breakage) (Herbig et al., 2006). The
ATM-signaling pathway is activated
and leads to extensive formation of
heterochromatin, a hallmark of cellular
senescence, along with upregulation of
p16INK4A (Herbig et al., 2006). Levels of
p16INK4A increase with the replicative
lifespan of cells in culture and in
human skin (7-fold induction). Conver-
sely, Bmi1, which is a repressor of
p16INK4A, decreases in skin with age
(Ressler et al., 2006). As key responders
in the early response to UV irradiation
(Abd Elmageed et al., 2009), it is not
surprising that disrupting either the p53
or p16INK4A pathways can lead to
melanoma and non-melanoma skin
cancers (Sharpless and DePinho,
1999; Ouhtit et al., 2000a, b; Recio
et al., 2002).
Beyond the skin, the increase of
reactive oxygen species with age also
activates the INK4A/ARF locus (Ito
et al., 2006), leading to impaired
regeneration of pancreatic islets, neu-
ronal progenitors, and the hematopoie-
tic system (Janzen et al., 2006;
Krishnamurthy et al., 2006; Molofsky
et al., 2006; Nishino et al., 2008).
Thus, while preventing cancers, these
proteins may be promoting senescence,
and thus aging (Collado et al., 2007).
This mechanism, a hypothesis known
as antagonistic pleiotropy, has been
suggested to be evolution’s way of
protecting organisms from cancer early
in life, but in doing so, promoting aging
phenotypes, perhaps providing an ex-
planation for why cancer is so rarely
seen in HGPS (Campisi, 2005).
REGENERATION AND RENEWAL:
STEM-CELL BIOLOGY
When the damage has been extensive
and the cell is forced to undergo
senescence or apoptosis, how does
the organism replace these cells and
go on? A reservoir of adult stem cells
appears to serve in this function,
though it is clear that stem-cell function
and the regenerative ability of different
tissues, such as the skin, declines with
age. Establishing whether this decline is
due to intrinsic stem-cell aging or
reduced function due to the aged skin
environment in which they reside
remains an open question (Rando,
2006; Sharpless and DePinho, 2007).
How exactly this might occur is an area
of intense interest and another area
from which insight can be gained from
HGPS and the progeroid syndromes.
Following the observation that the
Notch-signaling pathway, a major reg-
ulator of stem-cell maintenance and
differentiation, was upregulated in cells
expressing progerin, Scaffidi and Mis-
teli (2008) examined the effects of
progerin expression on human me-
senchymal stem cells, as the tissues
affected in progeria are of mesenchy-
mal origin. The introduction of proger-
in into mesenchymal stem cells not
only induced the Notch pathway, it
caused the mesenchymal stem cells to
undergo sporadic, undirected differen-
tiation into all three germ layers. This
effect may lead to premature exhaus-
tion of stem-cell pools, diminishing the
ability to regenerate damaged cells and
tissues, and therefore resulting in pre-
mature aging of tissues such as the
skin and vasculature (Gotzmann and
Foisner, 2006). Consistent with this,
another group has shown that disrup-
tion of the nuclear lamina disturbs
normal retinoblastoma protein function
and leads to inefficient cell-cycle arrest
and misregulation of the balance be-
tween proliferation and differentiation
of epidermal progenitor cells (Naetar
et al., 2008).
Taking another approach, Espada
et al. (2008) examined the relatively
well-described stem-cell niche of the
hair follicle and its bulge cells in the
progeroid Zmpste24-knockout mouse
model. Here, corresponding to the
levels of unprocessed and permanently
farnesylated lamin A, they found al-
tered nuclear architecture in the bulge
cells and increased numbers of resident
epidermal stem cells which had de-
creased proliferative potential. There
was also an increase in apoptosis of
supporting cells in the hair bulb region.
Analogous to the Notch findings de-
scribed above, Espada et al. (2008)
found a virtually complete absence of
transcriptionally active b-catenin, the
regulator of the Wnt-signaling path-
way, and Mitf, which is known to bind
b-catenin and regulate melanocyte
stem cells. As the Wnt pathway is a
master regulator of stem-cell self-re-
newal and cancer, and a promoter of
stem-cell proliferation in various stem-
cell niches, including the epidermis
(Reya and Clevers, 2005; Lowry and
Richter, 2007), the decreased epider-
mal stem-cell proliferation in these
cells is likely the result of the absence
of Wnt signaling. Most interestingly, all
of these cellular and organismal phe-
notypes are completely rescued in
Zmpste24/Lmnaþ / mice; in other
words, with one less copy of Lmna and
thus 50% less unprocessed and perma-
nently farnesylated lamin A around,
all phenotypes were normalized, a
direct correlation of mutant lamin A
and defective stem-cell regeneration
(Espada et al., 2008). Along these lines,
levels of normal lamin A are reduced
significantly in aged hematopoietic
stem cells (Chambers et al., 2007).
With increasing age, numerous
changes in the skin take place due to
both intrinsic and extrinsic forces
(McCullough and Kelly, 2006). Epider-
mal turnover, which occurs in approxi-
mately 28 days in young adults,
requires 40–60 days in the elderly
(Grove and Kligman, 1983). This
2346 Journal of Investigative Dermatology (2009), Volume 129
BC Capell et al.
From the Rarest to the Most Common
diminished renewal alters the
appearance of the skin, which may
become rougher, scalier, and more
transparent. The cellular content of
the dermis (mast cells, fibroblasts, and
macrophages) decreases, as does the
number and function of antigen-pre-
senting cells (Langerhans cells, mast
cells) (Swift et al., 2001). The decreased
numbers and function of melanocytes
leads to mottled pigmentation, and the
decrease both in melanocytes and in
Langerhans cells may increase the risk
of skin cancers as well (McCullough
and Kelly, 2006). A loss of subdermal
fat, seen clearly in HGPS, as well as
misregulation of normal collagen and
elastin production, leads to wrinkling,
sagging, and a general loss of support
and elasticity (Rabe et al., 2006). Thus,
might the increased levels of progerin
with age in human skin be impairing
regeneration and allowing for intrinsic
skin aging and all of its associated
defects?
In unaffected individuals, the case
for stem-cell dysfunction as a cause of
age-related changes in the skin has
been building. For instance, hair gray-
ing, a classic part of the aging pheno-
type, has been linked to decreased
melanocyte stem-cell maintenance,
possibly in association with melano-
blast senescence (Nishimura et al.,
2005). Likewise, an age-related decline
in the ability to heal wounds has long
been recognized. It has been shown
recently that hair follicles in wounds
regenerate de novo from epithelial cells
outside the hair follicle stem-cell niche,
suggesting that epidermal cells assume
a hair follicle stem-cell phenotype and
that this is dependent upon Wnt signal-
ing (Ito et al., 2007). Similarly, Wnt can
induce mesenchymal stem cells and
these contribute to wound healing and
regeneration, contributing to many cell
components of the skin (Sasaki et al.,
2008). Once again, the age-related
accumulation of progerin in the skin
might negatively impact stem-cell
maintenance through both direct ef-
fects on stem cells and upon normal
stem cell-signaling pathways such as
Wnt and Notch. Similarly, aberrant
DNA damage repair may also lead to
cancer or senescence and aging. In an
elegant study bringing together many of
these concepts, Rossi et al. (2007)
demonstrated that stem-cell function
declines with age in mice because of
DNA damage and that these aged stem
cells show dramatic epigenetic
changes and alterations in gene expres-
sion, damage and instability that may
also lead to increased chances of
transformation into cancer.
CONCLUSIONS
Recent advances made in the study of
rare progeroid syndromes, particularly
HGPS, have been groundbreaking,
though the questions and uncertainties
that remain are extensive. For instance,
what role does progerin play in the
skin? Is it a cause or byproduct of
aging? One thing that is certain, how-
ever, is that the study of these condi-
tions has provided novel insights and
opened up new avenues of exploration
into some of the most basic and
fundamental aspects of molecular and
cellular biology, with implications for
processes of vital importance to human
health, namely aging and cancer. As
Paget noted so long ago, by stopping
and looking for a moment at these most
rare and seemingly unique conditions,
we might yet be surprised at the
ubiquity of what they teach us.
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